“…Phage RBPs have evolved to recognize a variety of structures on the surfaces of their bacterial hosts, including protein complexes (e.g., porins and the flagella) and saccharidic components such as teichoic acids, lipopolysaccharides (LPS), and capsular polysaccharides [17] , [18] , [19] . The inherent specificity of RBPs for a given species has led to their implementation in bacterial diagnostics, such as recently developed assays for Listeria [20] , Salmonella [21] , [22] , Pseudomonas [23] , and Yersinia [24] detection. In addition, the ability of certain phage TSPs to enzymatically degrade the protective capsules of certain pathogens, e.g., E. coli [25] , Klebsiella pneumoniae [19] , [26] , and Acinetobacter baumannii [27] , [28] , has led to their investigation as anti-virulence agents to target multidrug resistant bacteria and re-sensitize them to antibiotics.…”